ICVTS Click here to locate an Ethicon representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2008;7:712-714. doi:10.1510/icvts.2008.176727
© 2008 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshikatsu Saiki
Koichi Tabayashi
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Saiki, Y.
Right arrow Articles by Tabayashi, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saiki, Y.
Right arrow Articles by Tabayashi, K.
Related Collections
Right arrow Mediastinum

Brief communication - Vascular thoracic

An effective vacuum-assisted closure treatment for mediastinitis with aortic arch replacement

Yoshikatsu Saiki*, Shunsuke Kawamoto, Sadahiro Sai and Koichi Tabayashi

Department of Cardiovascular Surgery, Graduate School of Medicine, Tohoku University, 1-1 Seiryomachi, Aoba-ku, Sendai 980-8574, Japan

Received 10 February 2008; received in revised form 6 May 2008; accepted 7 May 2008

*Corresponding author. Tel.: +81-22-717-7222; fax: +81-22-717-7227.

E-mail address: ysaiki{at}mail.tains.tohoku.ac.jp (Y. Saiki).


    Abstract
 Top
 Abstract
 1. Introduction
 2. Patients and method
 3. Results
 4. Discussion
 References
 
Little experience exists with the vacuum-assisted closure (VAC) therapy in the high-risk group of patients with perigraft abscess containing a large amount of prosthetic vascular grafts. We report our experience in the VAC therapy for patients with mediastinitis after aortic arch replacement. Between February 2003 and December 2006, five patients with a mean age of 72.2 years developed postoperative mediastinitis after aortic arch replacement, and were treated with the VAC system. In all the patients the mediastinal fluid and tissue examinations turned out to be negative for microbiological cultures, and successful closure of the midline incision was achieved with concomitant omental transfer after a mean duration of 22.6 days of VAC treatment. Four of the five patients survived to discharge and have been free from recurrent sign of mediastinal or graft infection at long-term follow-up. Our study indicates that the VAC treatment may reduce early mortality of life-threatening deep sternal wound infection complicated by a prior aortic arch replacement and become a preferred therapeutic option for the patients to whom another replacement is too risky.

Key Words: Mediastinal infection; Aortic arch; Postoperative care


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Patients and method
 3. Results
 4. Discussion
 References
 
Early mortality among the patients who had aortic arch replacement that resulted in mediastinitis is high [1]. Common treatments for them include surgical debridement, drainage, irrigation, and replacement of the prosthetic graft with an omental or a pectoral muscle flap. The graft, a foreign object, makes the infection management a challenge. A safe effective treatment for their mediastinitis has been sought.

The vacuum-assisted wound closure (VAC) system, commonly adopted for the treatment of pressure ulcers and other chronic wounds [2], is a relatively new non-invasive treatment that promotes granulation. It was previously described for the treatment of osteomyelitis and originally applied to mediastinal infection by Durandy et al. as early as in 1984 [3]. Its application has been steadily expanding and constitutes presently the treatment of choice in many institutes for post-sternotomy mediastinitis. However, its application to mediastinitis of patients who had aortic arch replacement is not yet widely known. The standard protocol for such mediastinitis at our facility has been a complete replacement of the infected graft with a homograft or xenograft. This option, however, is of great burden and unsuitable for severely infected patients.

The authors attempted to manage mediastinitis where a large amount of graft is used with the VAC system.


    2. Patients and method
 Top
 Abstract
 1. Introduction
 2. Patients and method
 3. Results
 4. Discussion
 References
 
Between February 2003 and December 2006, five patients with aortic arch replacement who developed mediastinitis were treated with the VAC system. The patients' demography and history are summarized in Table 1. In terms of the predisposing factors to mediastinitis, all the five except for patient no. 4 were septuagenarians. Early postoperative course in patient no. 1 was complicated with pneumonia and sepsis. Patient no. 2 underwent re-do aortic root replacement for prosthetic valve endocarditis with aortic annular abscess. Patient no. 3 had undergone multiple mediastinal exposure for delayed mediastinal bleeding due to coagulopathy associated with thoraco-abdominal aortic aneurysm. Bacterial translocation was suspected in patients no. 4 and 5 when mediastinitis was diagnosed. Patient no. 4 had developed brain abscess with methicillin-sensitive Staphylococcus aureus. Her CT-scan revealed mediastinitis with perigraft abscess (Fig. 1a,b).


View this table:
[in this window]
[in a new window]

 
Table 1 Summary

 

Figure 1
View larger version (100K):
[in this window]
[in a new window]

 
Fig. 1. Computed tomography (CT) demonstrated perigraft abscess at the aortic arch (a) and the ascending aorta level (b) in patient number 4. Follow-up CT-scan examined at 4 months after the VAC therapy showed no recurrent signs of perigraft abscess being replaced with the omentum (c, d). External appearance of the mediastinum at re-exploration in patient number 3 is shown in Fig. (e). The prosthetic graft for the aortic arch replacement infected with methicillin-resistant Staphylococcus aureus was treated with pyoktanin, a triphenylmethane dye, and appeared to be dry after the treatment. Postmorten examination after 16 months confirmed no residual or recurrent infection around the prosthetic graft surrounded by the omentum (f).

 
2.1. Installation of the VAC system

The VAC system components:
  • polyurethane foam (Hydrosite®, Smith & Nephew Inc., Florida, FL),
  • non-collapsible chest tube (BLAKE Drains®, Ethicon Inc., San Anglo, TX),
  • vacuum pump (HAMA Servo drain, Hama Medical Industrial Co. Ltd., Tokyo)
  • LAP sponge® (Kawamoto Co. Ltd., Osaka).
  • 3MTM IobanTM 2 antimicrobial incise drape (3M Health Care Inc., St. Paul, MN).

When a CT-scan confirmed mediastinitis, mediastinum of each patient was explored under general anesthesia in the operating room. Precise debridement and wound excision were followed by copious irrigation with warm saline. The deep sternal wound was then dressed with the VAC system that provided continuous pressure of –99 mmHg. A BLAKE Drain was placed in the middle of the incision and the incision perimeter was covered with LAP sponges. The wound was then covered with a 3M Ioban 2 antimicrobial incise drape. The mediastinum and the prosthetic grafts were observed everyday while the patient was sedated. Pyoktanin was applied for gram-positive micrococci, amply around the prosthetic grafts [4] (Fig. 1e).

2.2. Timing of sternal closure

When mediastinal tissue or gauze cultures became negative on multiple consecutive tests, the chest was closed transferring omentum or major pectoral muscle (Fig. 1c, 1d).


    3. Results
 Top
 Abstract
 1. Introduction
 2. Patients and method
 3. Results
 4. Discussion
 References
 
Mediastinitis was healed in all five patients (see Table 1). Four patients survived to discharge and have been free from recurrent infections of the lesion. Patient no. 3 died from rupture of the thoracoabdominal aortic aneurysm 16 months after chest closure. But his postmortem graft examination showed no signs of infection (Fig. 1f).


    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Patients and method
 3. Results
 4. Discussion
 References
 
Despite the condition of the five patients in this study being too severe for the standard protocol, VAC therapy was effective in such high-risk patients in managing mediastinal infection even with the presence of the prosthesis. The effectiveness of the VAC system on microcirculation and promotion of tissue granulation was also confirmed.

Removal of exudate from the mediastinal cavity and of the vascular graft surface also contributed to the successful infection management. Slime protects bacteria from antibiotics [5]. Extracellular glycocalyx slime is known as a virulence factor of many pathogenic bacteria, especially in the presence of biomaterial. Cytokines, radicals and nitrogen species secreted from blood monocytes and macrophages that are stimulated by cleavage products of gram positive bacteria, cause oxido-inflammatory damage [6]. Strong vacuum of the VAC was effective for elimination of slime ameliorating virulent local infection.

The negative pressure of the VAC system, much higher than that of a conventional drain, caused no adverse events such as anastomotic rupture and bleeding. The VAC imposed no pressure difference between prosthetic graft and the native aorta, and no suture lines were pulled apart. The VAC had no impact on hemodynamics and respiratory function either.

The VAC therapy can, by and large, eliminate the need for omentopexy or pectral muscle transfer in some mediastinal infections, since a strong negative pressure per se can enhance neovascularization in the mediastinal tissue. However, the presence of a large amount of prosthetic material limits the granulation around the prosthetic grafts. We believe that supplemental treatment using an omental or a pectral muscle flap is essential in the management of graft infection.

The VAC therapy augmented by pyoktanin and omentopexy as well as pectral muscle transfer was effective to treat mediastinitis that developed after aortic arch replacement. The successful VAC therapy may eliminate the need for high-risk replacement of prosthetic graft.


    References
 Top
 Abstract
 1. Introduction
 2. Patients and method
 3. Results
 4. Discussion
 References
 

  1. Coselli JS, Koksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg 1999;67:1990–1993.[Abstract/Free Full Text]
  2. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 1997;38:553–562.[Medline]
  3. Durandy Y, Batisse A, Bourel P, Dibie A, Lemoine G, Lecompte Y. Mediastinal infection after cardiac operation: a simple closed technique. J Thorac Cardiovasc Surg 1989;97:282–285.[Abstract]
  4. Higashi S, Miyamoto T, Hashizume K. Experience with pyoktanin lavage for mediastinitis and prosthetic graft infection following thoracic aortic surgery. (in Japanese). Kyobu Geka 2002;55:379–382.[Medline]
  5. Ferguson DA Jr, Veringa EM, Mayberry WR, Overbeek BP, Lambe DW Jr, Verhoef J. Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes. Microbios 1992;69:53–65.[Medline]
  6. Ersoz G, Aytacoglu BN, Sucu N, Tamer L, Bayindir I, Kose N, Kaya A, Dikmengil M. Comparison and evaluation of experimental mediastinitis models: precolonized foreign body implants and bacterial suspension inoculation seems promising. BMC Infect Dis 2006;6:76–82.[CrossRef][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshikatsu Saiki
Koichi Tabayashi
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Saiki, Y.
Right arrow Articles by Tabayashi, K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saiki, Y.
Right arrow Articles by Tabayashi, K.
Related Collections
Right arrow Mediastinum


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS